Growth hormone deficiency in adulthood: How to diagnose and when to treat?;Deficiência de GH na vida adulta: Como diagnosticar e quando tratar?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 5, 2008, Pages 861-871

  Jallad, Raquel S ^a   Bronstein, Marcello D ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Adult growth hormone deficiency; GH; Growth hormone deficiency; hRGH replacement therapy; Hypopituitarism

Indexed keywords

EID: 52149085643     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000500019     Document Type: Review

References (36)

1. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-8.
2. Tomlinson JW, Holden N, Hills RK, WheatleyK, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlans Prospective Hypopituitary Study Group. Lancet. 2001;357:425-31.
3. Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS, et al. Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab. 2003;88:3664-7.
4. Svensson J, Bengtsson B-Å, Rosén T, Odén A, Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab Svensson. 2004;89(7):3306-12.
5. Drake WM, Howell SJ, Monson JP, Shalet SM. Optimising GH therapy in adults and children. Review. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Endocr Rev. 2001;22:425-50.
6. GHRS: consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society (GHRS) workshop on adult growth hormone deficiency. J Clin Endocrinol Metab. 1998;83: 379-81.
7. Ken KY. Ho on behalf of the 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157(6):695-700.
8. Ghigo E, Aimaretti G, Cornelli G. The diagnosis of adult growth hormone deficiency. Growth Horm IGF Res. 2007;18:1-16.
9. Nilsson A, Svensson J, Johannsson G. The management of growth hormone deficiency in adults. Growth Horm IGF Res. 2007;17:441-62.
10. Doga M, Bonadonna S, Gola M, Solerte SB, Amato G, Carella C, et al. Current guidelines for adult GH replacement. Rev Endocr Metab Disord. 2005;6(1):63-70.
11. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, et al. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1621-34.
12. Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, Degli Uberti EC. Hypopituitarism after traumatic brain injury. Eur J Endocrinol. 2005;152(5):679-91.
13. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf).1994;41:511-6.
14. Hartman ML, Crowe BJ, Biller BMK, Ho KKY, Clemmons DR, Chipman JJ on behalf of the HypoCCS Advisory Board and the U.S. HypoCCS Study Group. Which Patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002;87(2):477-85.
15. Holmes SJ, Shalet SM. Which adults develop side-effects of growth hormone replacement? Clin. Endocrinol (Oxf). 1995;43:143-9.
16. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J. 2007 A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab. 2007;92:1442-5.
17. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 1997;82(1):82-8.
18. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081-8.
19. Johannsson G, Gibney J, Wolthers T, Leung KC, Ho KKY. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. J Clin Endocrinol Metab. 2005;90(7):3989-94.
20. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab. 1996;81:1575-81.
21. Vahl N, Moller N, Lauritzen T, Christiansen JS, Jorgensen JOL. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J Clin Endocrinol Metab. 1997;82:1-7.
22. Weissberger AJ, Ho KKY, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insuline-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72:374-81.
23. Kelly JJ, Rajkovic IA, O'Sullivan AJ, et al. Effects of different oral oestrogen formulations on insuline-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 1993;39:561-7.
24. Murray RD, Adams JE, Shalet SM. Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab. 2004;89(4):1586-91.
25. Bosaeus I, Johannsson G, Rosén T, et al. Comparison of methods to estimate body fat in growth hormone deficient adults. Clin Endocrinol (Oxf). 1996;44:395-402.
26. Davidson P, Milne R, Chase D, Cooper C. Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2004;60:92-8.
27. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F. Long-term skeletal effects of recombinant human growth hormone (hrGH) alone and hrGH combined with alendronate in GH-deficient adults: a seven-year follow-up study. Clin Endocrinol (Oxf). 2004;60:568-75.
28. van der Sluis I, Boot AM, Hop WC, De Rijke YB, Krenning EP, de Muinck Keizer-Schrama SM. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study. Horm Res. 2002;58:207-14.
29. Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab. 2004;89(5):2192-9.
30. Jallad RS, Liberman B, Vianna CB, Vieira ML, Ramires JA, Knoepfelmacher M. Effects of growth hormone replacemnet therapy on metabolic and cardiac parameters, in adult with childhood-onset growth hormone deficiency. Growth Hormon IGF Res. 2003;13(2-3):81-8.
31. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol. 1958;18:901-3.
32. Arwert LI, Deijen JB, Witlox J, Drent ML. The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Horm IGF Res. 2005;15(1):47-54.
33. Soares CN, Musolino NR, Cunha Neto M, Caires MA, Rosenthal MC, Camargo CP, et al. Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults: a placebo-controlled trial. Arq Neuropsiquiatr. 1999; 57(2A):182-9.
34. Kołtowska-Häggström M, Kind P, Monson JP, Jonsson B. Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis. Clin Endocrinol (Oxf). 2008;68(1):122-9.
35. Arwert LI, Roos JC, Lips P, Twisk JWR, Manoliu RA, Drent ML. Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clin Endocrinol (Oxf). 2005;63(3):310-6.
36. Brooke AM, Monson JP. Do all adults with growth hormone deficiency require growth hormone treatment? Ann Med. 2003;35(6):419-24.